Compound information
- Natural Products
- ZC1300130
- Molecular Formula
- C21H24N2O6S
- Molecular Weight
- 432.135507488 g/mol
- Structure
-
- IUPAC Name
- (4-methylsulfanylphenyl) (2S)-2-[[(2S)-2-(benzyloxycarbonylamino)-3-hydroxy-propanoyl]amino]propanoate
- InChI
- InChI=1S/C21H24N2O6S/c1-14(20(26)29-16-8-10-17(30-2)11-9-16)22-19(25)18(12-24)23-21(27)28-13-15-6-4-3-5-7-15/h3-11,14,18,24H,12-13H2,1-2H3,(H,22,25)(H,23,27)/t14-,18-/m0/s1
- InChI Key
- UTPMZVGGVNZEHT-KSSFIOAISA-N
- SMILES
- CSc1ccc(OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)OCc2ccccc2)cc1
- Source
- ZINC000005201570
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.96 Å2 | LogP | 2.334 |
LogS | -4.273 | LogD | 3.181 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.063 |
HIA | 0.935 | F20 % | 0.975 |
F30 % | 0.219 | Caco-2 | -5.375 |
MDCK | -5.147 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.016 | PPB | 96.3 |
VD | 0.536 | Fu | 1.871 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.232 | CYP1A2 substrate | 0.66 |
CYP2A6 substrate | 0.556 | CYP2B6 substrate | 0.609 |
CYP2C19 inhibitor | 0.419 | CYP2C19 substrate | 0.965 |
CYP2C8 substrate | 0.888 | CYP2C9 inhibitor | 0.073 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.04 |
CYP2D6 substrate | 0.949 | CYP2E1 substrate | 0.233 |
CYP3A4 inhibitor | 0.031 | CYP3A4 substrate | 0.986 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.686 | CL | 6.824 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.011 | Hepatotoxicity | 0.857 |
Mutagenicity | 0.01 | Rat Oral Acute Toxicity | 0.041 |
FDAMDD | 0.347 | Skin Sensitization | 0.739 |
Carcinogenicity | 0.011 | Eye Corrosion | 0.006 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.02 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.247 | IGC50 | 3.382 |
LC50FM | 4.217 | LC50DM | 6.2 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.237 | NR-AR-LBD | 0.214 |
NR-AhR | 0.006 | NR-Aromatase | 0.099 |
NR-ER | 0.461 | NR-ER-LBD | 0.394 |
NR-PPAR-gamma | 0.301 | SR-ARE | 0.314 |
SR-ATAD5 | 0.527 | SR-HSE | 0.194 |
SR-MMP | 0.157 | SR-p53 | 0.215 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.